IL-6 serves as a marker of SIRS with dual pro-inflammatory and anti-inflammatory effects, produced by a variety of cells, including cardiomyocytes, fibroblasts, and endothelial cells [46,47]. The gene discussed is IL6; the disease is systemic inflammatory response syndrome.